[go: up one dir, main page]

AR069530A1 - Procedimiento para la fabricacion de un derivado de indolinona - Google Patents

Procedimiento para la fabricacion de un derivado de indolinona

Info

Publication number
AR069530A1
AR069530A1 ARP080105253A ARP080105253A AR069530A1 AR 069530 A1 AR069530 A1 AR 069530A1 AR P080105253 A ARP080105253 A AR P080105253A AR P080105253 A ARP080105253 A AR P080105253A AR 069530 A1 AR069530 A1 AR 069530A1
Authority
AR
Argentina
Prior art keywords
manufacture
compound
formula
procedure
indolinone
Prior art date
Application number
ARP080105253A
Other languages
English (en)
Inventor
Joern Merten
Juergen Schnaubelt
Svenja Renner
Werner Rall
Guenter Linz
Carsten Reichel
Robert Schiffers
Rolf Schmid
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR069530A1 publication Critical patent/AR069530A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un procedimiento para la fabricacion de un derivado específico de la indolinona y una sal farmacéuticamente aceptable de la misma, a saber, la 3-Z-[1-(4-(N-((4-metil-piperazin-1-iI)-metilcarbonil)-N-metil-amino)-anilino)-1-fenil-metilen]-6-metoxicarbonil-2-indolinona y su monoetanosulfonato, nuevas etapas de fabricacion y procesos para obtener los reactivos utilizados en dicho proceso. Reivindicacion 1: Procedimiento para fabricar un compuesto de la formula (1) caracterizado porque comprende la etapa de hacer reaccionar un compuesto de la formula (2) con un compuesto de la formula (3).
ARP080105253A 2007-12-03 2008-12-02 Procedimiento para la fabricacion de un derivado de indolinona AR069530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122122 2007-12-03

Publications (1)

Publication Number Publication Date
AR069530A1 true AR069530A1 (es) 2010-01-27

Family

ID=40452557

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105253A AR069530A1 (es) 2007-12-03 2008-12-02 Procedimiento para la fabricacion de un derivado de indolinona

Country Status (21)

Country Link
US (1) US8304541B2 (es)
EP (1) EP2229359B1 (es)
JP (1) JP5269907B2 (es)
KR (1) KR20100094497A (es)
CN (1) CN101883756A (es)
AR (1) AR069530A1 (es)
AU (1) AU2008333286B2 (es)
BR (1) BRPI0820689A2 (es)
CA (1) CA2706423A1 (es)
CL (1) CL2008003598A1 (es)
DK (1) DK2229359T3 (es)
ES (1) ES2658091T3 (es)
HU (1) HUE036390T2 (es)
IL (1) IL205389A (es)
MX (1) MX2010005556A (es)
NZ (1) NZ585799A (es)
PL (1) PL2229359T3 (es)
RU (1) RU2525114C2 (es)
TR (1) TR201802086T4 (es)
TW (1) TWI432424B (es)
WO (1) WO2009071523A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
CN104829596B (zh) * 2014-02-10 2017-02-01 石家庄以岭药业股份有限公司 吡咯取代吲哚酮类衍生物、其制备方法、包含该衍生物的组合物、及其用途
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN106008308A (zh) * 2015-03-13 2016-10-12 正大天晴药业集团股份有限公司 尼达尼布乙磺酸盐结晶
WO2016178064A1 (en) * 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN104844499B (zh) * 2015-06-05 2017-03-08 北京康立生医药技术开发有限公司 一锅法制备尼达尼布的合成方法
CN105126909B (zh) * 2015-07-13 2018-01-23 淮海工学院 固载钯催化剂在4‑苯乙炔基‑3‑硝基苯甲酸甲酯合成中的应用
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
CZ308695B6 (cs) 2015-07-29 2021-03-03 Zentiva, K.S. Způsob přípravy methyl (Z)-3[[4-[methyl[2-(4-methyl-1piperazinyl)acetyl]amino]fenyl]amino]fenylmethylen)-oxindol-6karboxylátu (intedanibu, nintedanibu)
CN106432042A (zh) * 2015-08-13 2017-02-22 南京华威医药科技开发有限公司 尼达尼布乙磺酸水合物的药物新晶型
CN106467500A (zh) * 2015-08-14 2017-03-01 廊坊百瑞化工有限公司 一种一锅煮法合成尼达尼布关键中间体的新方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
CN105418483A (zh) * 2015-12-15 2016-03-23 南京艾德凯腾生物医药有限责任公司 一种结晶型乙磺酸尼达尼布的制备方法
CN105461609B (zh) * 2015-12-25 2019-08-23 杭州新博思生物医药有限公司 一种尼达尼布的制备方法
CN105837493B (zh) * 2016-04-08 2018-12-14 东南大学 尼达尼布的合成方法及其中间体
CN109415314A (zh) * 2016-05-19 2019-03-01 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN107935909B (zh) * 2016-10-13 2023-03-17 上海科胜药物研发有限公司 一种尼达尼布（nintedanib）及其中间体的合成方法
CN109803954B (zh) * 2016-10-12 2021-12-07 浙江华海药业股份有限公司 尼达尼布及其中间体的制备方法
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
JP7306697B2 (ja) 2017-03-14 2023-07-11 オールジェネシス バイオセラピューティクス インコーポレイテッド ３－ｚ－［１－（４－（ｎ－（（４－メチル－ピペラジン－１－イル）－メチルカルボニル）－ｎ－メチル－アミノ）－フェニルアミノ）－１－フェニル－メチレン］－６－メトキシカルボニル－２－インドリノンの結晶形
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
CA3082714A1 (en) 2017-11-17 2019-05-23 Fermion Oy Synthesis of a 2-indolinone derivative known as intermediate for preparing nintedanib
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111004141B (zh) * 2019-12-19 2022-10-04 苏州诚和医药化学有限公司 一种尼达尼布中间体2-氯-n-甲基-n-(4-硝基苯基)乙酰胺合成新方法
AU2021321561A1 (en) * 2020-08-07 2023-03-09 Bdr Lifesciences Private Limited An improved highly efficient process for the prepration of nintedanib and pharmaceutically acceptable salt thereof
CN115181078B (zh) * 2022-07-27 2024-07-19 安徽修一制药有限公司 一种尼达尼布关键中间体的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL346898A1 (en) 1998-09-25 2002-03-11 Boehringer Ingelheim Pharma Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
UA75054C2 (uk) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments

Also Published As

Publication number Publication date
TR201802086T4 (tr) 2018-03-21
TWI432424B (zh) 2014-04-01
ES2658091T3 (es) 2018-03-08
IL205389A (en) 2014-11-30
JP5269907B2 (ja) 2013-08-21
AU2008333286A1 (en) 2009-06-11
PL2229359T3 (pl) 2018-04-30
DK2229359T3 (en) 2018-02-05
EP2229359B1 (en) 2017-11-29
HUE036390T2 (hu) 2018-07-30
NZ585799A (en) 2012-04-27
KR20100094497A (ko) 2010-08-26
WO2009071523A1 (en) 2009-06-11
EP2229359A1 (en) 2010-09-22
RU2525114C2 (ru) 2014-08-10
CN101883756A (zh) 2010-11-10
MX2010005556A (es) 2010-08-11
BRPI0820689A2 (pt) 2019-09-24
CL2008003598A1 (es) 2010-02-12
US20110201812A1 (en) 2011-08-18
AU2008333286B2 (en) 2014-08-14
CA2706423A1 (en) 2009-06-11
TW200932739A (en) 2009-08-01
JP2011504919A (ja) 2011-02-17
RU2010126906A (ru) 2012-01-10
US8304541B2 (en) 2012-11-06
IL205389A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
AR069530A1 (es) Procedimiento para la fabricacion de un derivado de indolinona
CL2007002949A1 (es) Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora;
ECSP055610A (es) Nuevo proceso para la síntesis de ivabradina y sales de adición de la misma con un ácido farmacéuticamente aceptable
NO330968B1 (no) Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
EA200901039A1 (ru) Способ получения производного бензимидазола
CY1113985T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
CY1110520T1 (el) Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδη
UY29219A1 (es) Sales de la n-(2- (((3r)-1-(trans-4-hidroxi-4-(6-metoxipiridin-3-il)-cilohexil) pirrolidin-3-il)amino)-2-oxoetil)-3- (trifluorometil) benzamida
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
EA200901051A1 (ru) Новый способ разделения энантиомеров (3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил)нитрила и применение при синтезе ивабрадина
CL2009001487A1 (es) Procesos para la síntesis convergente de los derivados de caliqueamicina. (divisional de sol. 442-2007)
CL2009001414A1 (es) Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina.
TW200833660A (en) Synthesis of pyrrolidine compounds
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
EA200970875A1 (ru) Производные индолизинуксусной кислоты в качестве антагонистов crth2
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
DK1713801T3 (da) Fremgangsmåde til fremstilling af 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amin
EA200701738A1 (ru) Способ получения транс-1-((1r,3s)-6-хлор-3-фенилиндан-1-ил)-3,3-диметилпиперазина
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
AR051341A1 (es) Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina
NI200700227A (es) Procesos para la purificación de compuestos benzoxazol sustituidos.
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
NI200700175A (es) Procesos para la preparación de alcoholes de aminoetoxibencilo
NO20064884L (no) Kjemisk fremgangsmate og ny krystallinsk form
AR058019A1 (es) Proceso de preparacion de un derivado de pirrolopirimidina

Legal Events

Date Code Title Description
FB Suspension of granting procedure